Quest Diagnostics (DGX) Revenue (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Revenue data on file, last reported at $2.9 billion in Q1 2026.

• Quarterly Revenue rose 9.16% year-over-year to $2.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 billion (up 11.03% YoY) and the FY2025 annual result came in at $11.0 billion, up 11.78% from the prior year.
• Revenue rose to $2.9 billion in Q1 2026 per DGX's latest filing, from $2.8 billion in the prior quarter.
• The five-year high for Revenue was $2.9 billion in Q1 2026, with the low at $2.3 billion in Q4 2023.
• Average Revenue over 5 years is $2.5 billion, with a median of $2.5 billion recorded in 2022.
• Year-over-year, Revenue declined 14.98% in 2022 and rose 15.19% in 2025.
• Quest Diagnostics' Revenue stood at $2.3 billion in 2022, then retreated by 1.93% to $2.3 billion in 2023, then advanced by 14.55% to $2.6 billion in 2024, then climbed by 7.06% to $2.8 billion in 2025, then rose by 3.17% to $2.9 billion in 2026.
• Business Quant data shows DGX's Revenue at $2.9 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.8 billion in Q3 2025.